During the consultation on the draft guidance Janssen, the manufacturer of the drug, submitted further information for the committee to consider.
This included a revised patient access scheme which involves providing the drug to the NHS at a discounted price, further information on which patients would benefit most and clarification on how many patients could receive the drug.
These factors enabled the committee to revise its preliminary recommendation and now recommend the drug for use on the NHS.
More top news
Prime Minister plans a whistle-stop charm offensive with EU leaders this week.
Thriller writer Anthony Horowitz is at the helm of the latest Bond book, which is based on an unfilmed Ian Fleming TV script.
Actress who plays iconic Daenerys Targaryen admitted she didn't want to become typecast for nudity.